Webbläsaren som du använder stöds inte av denna webbplats. Alla versioner av Internet Explorer stöds inte längre, av oss eller Microsoft (läs mer här: * https://www.microsoft.com/en-us/microsoft-365/windows/end-of-ie-support).

Var god och använd en modern webbläsare för att ta del av denna webbplats, som t.ex. nyaste versioner av Edge, Chrome, Firefox eller Safari osv.

G Protein-Coupled Receptor 39 Deficiency Is Associated with Pancreatic Islet Dysfunction

In English

Författare

  • Birgitte Holst
  • Kristoffer L. Egerod
  • Chunyu Jin
  • Pia Steen Petersen
  • Mette Viberg Ostergaard
  • Jacob Hald
  • A. M. Ejernaes Sprinkel
  • Joachim Storling
  • Thomas Mandrup-Poulsen
  • Jens J. Holst
  • Peter Thams
  • Cathrine Orskov
  • Nils Wierup
  • Frank Sundler
  • Ole D. Madsen
  • Thue W. Schwartz
Visa allt

Summary, in English

G protein-coupled receptor (GPR)-39 is a seven-transmembrane receptor expressed mainly in endocrine and metabolic tissues that acts as a Zn++ sensor signaling mainly through the G(q) and G(12/13) pathways. The expression of GPR39 is regulated by hepatocyte nuclear factor (HNF)-1 alpha and HNF-4 alpha, and in the present study, we addressed the importance of GPR39 for glucose homeostasis and pancreatic islets function. The expression and localization of GPR39 were characterized in the endocrine pancreas and pancreatic cell lines. Gpr39(-/-) mice were studied in vivo, especially in respect of glucose tolerance and insulin sensitivity, and in vitro in respect of islet architecture, gene expression, and insulin secretion. Gpr39 was down-regulated on differentiation of the pluripotent pancreatic cell line AR42J cells toward the exocrine phenotype but was along with Pdx-1 strongly up-regulated on differentiation toward the endocrine phenotype. Immunohistochemistry demonstrated that GRP39 is localized selectively in the insulin-storing cells of the pancreatic islets as well as in the duct cells of the exocrine pancreas. Gpr39(-/-) mice displayed normal insulin sensitivity but moderately impaired glucose tolerance both during oral and iv glucose tolerance tests, and Gpr39(-/-) mice had decreased plasma insulin response to oral glucose. Islet architecture was normal in the Gpr39 null mice, but expression of Pdx-1 and Hnf-1 alpha was reduced. Isolated, perifused islets from Gpr39 null mice secreted less insulin in response to glucose stimulation than islets from wild-type littermates. It is concluded that GPR39 is involved in the control of endocrine pancreatic function, and it is suggested that this receptor could be a novel potential target for the treatment of diabetes. (Endocrinology 150: 2577-2585, 2009)

Publiceringsår

2009

Språk

Engelska

Sidor

2577-2585

Publikation/Tidskrift/Serie

Endocrinology

Volym

150

Dokumenttyp

Artikel i tidskrift

Förlag

Oxford University Press

Ämne

  • Endocrinology and Diabetes

Conference name

Keystone Meeting on Beta-Cell Function

Conference date

2008-04-06 - 2008-04-11

Status

Published

ISBN/ISSN/Övrigt

  • ISSN: 0013-7227